Quantitative Total Extensible Imaging (QTxI) vs PeraMobile and PeraWatch
AI Verdict
Choose Quantitative Total Extensible Imaging (QTxI) if…
Choose Quantitative Total Extensible Imaging (QTxI) if your clinical workflow requires precise, quantitative analysis of digital medical images (DICOM CT and PET) for detailed treatment monitoring, particularly in oncology. This tool is ideal for identifying, contouring, and statistically analyzing changes in specific Regions of Interest over time to assess disease progression or treatment response.
View Quantitative Total Extensible Imaging (QTxI) →Choose PeraMobile and PeraWatch if…
Choose PeraMobile and PeraWatch if your organization needs a system-wide predictive analytics solution to proactively identify patients at risk of deterioration across various care settings. This platform, powered by the FDA-cleared Rothman Index, integrates with EHRs to provide real-time acuity scores, mobile alerts, and virtual surveillance for earlier intervention and improved patient outcomes.
View PeraMobile and PeraWatch →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Quantitative Total Extensible Imaging (QTxI) | PeraMobile and PeraWatch |
|---|---|---|
| Pricing | Contact for pricing | Contact for pricing |
| Deployment | Cloud-based | Software-only, integrated with EHRs, web-based access, mobile application, on user-provided hardware. |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
PeraMobile and PeraWatchTool B (PeraMobile/PeraWatch) explicitly highlights mobile and web-based access, along with EHR integration, suggesting a more flexible and integrated user experience for clinicians on the go. Tool A (QTxI) focuses on complex image analysis with 3D rendering but does not emphasize the same breadth of access or integration for diverse clinical workflows.
Clinical Value
TieBoth tools are FDA-cleared and offer significant clinical value in their respective domains. Tool A provides specialized quantitative imaging analysis for oncology treatment monitoring, offering precise data for a critical area of cancer care. Tool B offers broader predictive analytics for patient deterioration across various conditions, enabling earlier intervention and potentially wider impact on patient safety and operational efficiency across a hospital system.
Pricing & Value
TieBoth tools require direct contact with the vendor for custom, enterprise-level pricing. No public pricing details or specific value propositions are disclosed for either product, making a direct comparison of pricing transparency or overall value impossible.
Enterprise Readiness
PeraMobile and PeraWatchTool B (PeraMobile/PeraWatch) explicitly mentions integration with major EHR vendors, web-based access, and mobile applications, which are critical for seamless deployment and adoption in large healthcare systems. While Tool A (QTxI) is cloud-based and HIPAA compliant, it does not detail the same level of explicit integration or access flexibility for enterprise environments.
Innovation
TieBoth tools demonstrate significant innovation in their respective fields. Tool A's automated quantitative analysis of medical images for oncology treatment monitoring offers a specialized and impactful innovation in precision medicine. Tool B's real-time predictive analytics, powered by the well-established Rothman Index, for patient deterioration provides a broad and recognized innovative approach to proactive patient care across diverse clinical settings.
Support & Docs
TieNeither the provided structured facts nor readily available public web searches offer specific details on the depth or breadth of support and documentation for either product. As enterprise solutions, both are presumed to offer standard support, but without specific comparative information, a distinction cannot be made.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Quantitative Total Extensible Imaging (QTxI) | PeraMobile and PeraWatch |
|---|---|---|
| Tool Name | Quantitative Total Extensible Imaging (QTxI) | PeraMobile and PeraWatch |
| Company | AIQ Solutions | PeraHealth (acquired by Spacelabs Healthcare) |
| Primary Function | Software tool for medical professionals to evaluate and manage digital medical images (DICOM CT and PET), enabling quantitative analysis of Regions of Interest for improved treatment monitoring, particularly in oncology. | Predictive analytics solutions to help healthcare providers identify at-risk patients sooner for earlier intervention, improve quality, and reduce costs. |
| Key Data Input/Modality | Digital medical images (DICOM CT and PET) | Patient data (for real-time patient acuity scoring, likely from EHRs) |
| Key Analytical Capability | Quantitative and statistical analysis of full or partial-body scans, 3D interactive rendering of images with highlighted ROIs, automated quantification of ROIs and changes in ROIs. | Real-time patient acuity scoring (Rothman Index), predictive analytics for patient deterioration, system-wide virtual surveillance. |
Videos
Demos, reviews, and walkthroughs featuring Quantitative Total Extensible Imaging (QTxI) and PeraMobile and PeraWatch.